Sources | Names Used |
---|---|
CTRPv2 | tretinoin:navitoclax (4:1 mol/mol) |
PharmacoGx | tretinoin:navitoclax (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ZNF419 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | NOS1AP | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | MAPT | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | INSRR | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | C19orf57 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | ZNF407 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | NHLH1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | RXRB | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | PCDHA12 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | SLC36A4 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |